Exero Medical
Founded 2018 · 18 employees on LinkedIn · 5 known investors
Find your way into Exero Medical
Exero Medical develops the xBar system, which uses electrode sensors embedded in a standard surgical drain to non-invasively monitor post-operative tissue healing and detect anastomotic leaks after gastrointestinal surgery. The system provides healthcare providers with post-operative data to enable earlier detection of complications; it is currently limited to investigational use in the US.
Founders & leadership
Exero Medical was founded in 2018 by Erez Shor.
ES

Erez ShorinCEO
MB

Matan Ben DavidMedical Director
Investors · 5
Longevity Venture PartnersPikesville
Tech Council VenturesSummit · $500K – $3M
Israel Innovation AuthorityreportedJerusalem · $140K – $5M
Also in the syndicate · 2
CBG GroupEdge Medical Ventures
Funding
SEC filings, press & company announcements$14M disclosed across 2 rounds · 2021–2025
- $12.7MseedFeb 2025 · 2 sources
Longevity Venture Partners (lead), Edge Medical Ventures, Tech Council Ventures
Source ↗ - $1.3MSAFEDec 2021 · 2 sources
CBG Group, Israel Innovation Authority
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Exero Medical do?
- Exero Medical develops the xBar system, which uses electrode sensors embedded in a standard surgical drain to non-invasively monitor post-operative tissue healing and detect anastomotic leaks after gastrointestinal surgery. The system provides healthcare providers with post-operative data to enable earlier detection of complications; it is currently limited to investigational use in the US.
- Who founded Exero Medical?
- Exero Medical was founded by Erez Shor in 2018.
- Who are Exero Medical's investors?
- Exero Medical's investors include Longevity Venture Partners, Tech Council Ventures, Israel Innovation Authority.
- How much funding has Exero Medical raised?
- Exero Medical has disclosed $14M raised across 2 rounds.


